Literature DB >> 7704267

A defined growth medium for Clostridium difficile.

T Karasawa1, S Ikoma, K Yamakawa, S Nakamura.   

Abstract

Minimal requirements of amino acids and vitamins were determined in chemically defined medium for five strains of Clostridium difficile. Cysteine, isoleucine, leucine, proline, tryptophan and valine were essential amino acids for growth of C. difficile. Arginine, glycine, histidine, methionine and threonine enhanced growth. Biotin, pantothenate and pyridoxine were essential vitamins. A defined medium containing the minimal requirements of amino acids and vitamins produced a rapid and heavy growth which was comparable to that in modified brain heart infusion, a complex medium. Adenine was able to substitute for glycine and threonine, suggesting that the two amino acids may be utilized as precursors of purine nucleotides. The defined medium developed here will assist physiological and biochemical studies on C. difficile.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7704267     DOI: 10.1099/13500872-141-2-371

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  76 in total

1.  Mechanism of action of and mechanism of reduced susceptibility to the novel anti-Clostridium difficile compound LFF571.

Authors:  J A Leeds; M Sachdeva; S Mullin; J Dzink-Fox; M J Lamarche
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

Review 2.  Eating for two: how metabolism establishes interspecies interactions in the gut.

Authors:  Michael A Fischbach; Justin L Sonnenburg
Journal:  Cell Host Microbe       Date:  2011-10-20       Impact factor: 21.023

3.  Toxins, butyric acid, and other short-chain fatty acids are coordinately expressed and down-regulated by cysteine in Clostridium difficile.

Authors:  S Karlsson; A Lindberg; E Norin; L G Burman; T Akerlund
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Pleiotropic role of the RNA chaperone protein Hfq in the human pathogen Clostridium difficile.

Authors:  P Boudry; C Gracia; M Monot; J Caillet; L Saujet; E Hajnsdorf; B Dupuy; I Martin-Verstraete; O Soutourina
Journal:  J Bacteriol       Date:  2014-06-30       Impact factor: 3.490

Review 5.  Interactions Between the Gastrointestinal Microbiome and Clostridium difficile.

Authors:  Casey M Theriot; Vincent B Young
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

6.  Action of nitroheterocyclic drugs against Clostridium difficile.

Authors:  Manish Kumar; Sudip Adhikari; Julian G Hurdle
Journal:  Int J Antimicrob Agents       Date:  2014-07-25       Impact factor: 5.283

Review 7.  Role of the intestinal microbiota in resistance to colonization by Clostridium difficile.

Authors:  Robert A Britton; Vincent B Young
Journal:  Gastroenterology       Date:  2014-02-04       Impact factor: 22.682

8.  Analysis of proline reduction in the nosocomial pathogen Clostridium difficile.

Authors:  Sarah Jackson; Mary Calos; Andrew Myers; William T Self
Journal:  J Bacteriol       Date:  2006-10-13       Impact factor: 3.490

9.  Proline-dependent regulation of Clostridium difficile Stickland metabolism.

Authors:  Laurent Bouillaut; William T Self; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2012-12-07       Impact factor: 3.490

10.  Clostridioides difficile uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea.

Authors:  Eric J Battaglioli; Vanessa L Hale; Jun Chen; Patricio Jeraldo; Coral Ruiz-Mojica; Bradley A Schmidt; Vayu M Rekdal; Lisa M Till; Lutfi Huq; Samuel A Smits; William J Moor; Yava Jones-Hall; Thomas Smyrk; Sahil Khanna; Darrell S Pardi; Madhusudan Grover; Robin Patel; Nicholas Chia; Heidi Nelson; Justin L Sonnenburg; Gianrico Farrugia; Purna C Kashyap
Journal:  Sci Transl Med       Date:  2018-10-24       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.